Can Antitrust Laws Prevent Abuse Of FDA Risk Programs?

Law360, New York ( September 4, 2013, 12:36 PM EDT) -- For decades we have recognized how the regulatory process can be a fertile environment to secure and abuse market power. Outside the regulatory realm, when market power is secured we can expect the normal forces of competition to often dissipate that power, through new entry or expansion, of other competitive forces. But where market power is secured through regulatory abuse there is no competitive force that can dislodge that power. That is why the antitrust agencies have appropriately focused on regulatory abuse in its enforcement agenda....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!